Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial-Reference-Cited by-同舟云学术

Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial

Published:2017-02-01 Issue:8 Volume:18 Page:537-545
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Gallien S¹²^ORCID,Journot V³,Loriot M-A⁴⁵⁶,Sauvageon H⁷,Morlat P⁸,Reynes J⁹,Reliquet V¹⁰,Chêne G³,Molina J-M¹²,

Affiliation:

1. Sorbonne Paris Cité; Université Paris Diderot Paris 7; Paris France

2. Assistance Publique-Hôpitaux de Paris (AP-HP); Service de Maladies Infectieuses; Hôpital Saint-Louis; Paris France

3. INSERM U1219; Bordeaux France

4. Université Paris Descartes; Sorbonne Paris Cité; Paris France

5. INSERM UMR_S1147; Centre Universitaire des Saints-Pères; Paris France

6. Assistance Publique-Hôpitaux de Paris (AP-HP); Service de Biochimie; Hôpital Européen Georges Pompidou; Paris France

7. Assistance Publique-Hôpitaux de Paris (AP-HP); Pharmacie; Hôpital Saint-Louis; Paris France

8. Service de médecine interne; Hôpital Saint-André; Bordeaux France

9. Département des Maladies Infectieuses et Tropicales; Centre Hospitalier Universitaire Montpellier; Montpellier France

10. Service de Maladies Infectieuses; CHU Nantes; Nantes France

Funder

Agence Nationale de Recherches sur le Sida et les Hepatites Virales

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hiv.12488/fullpdf

Reference42 articles.

1. Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf

2. European AIDS Clinical Society Guidelines http://www.eacsociety.org/files/2015_eacsguidelines_8.0-english_rev-20151221.pdf

3. Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study;Smith;J Int AIDS Soc,2014

4. No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database;Napoli;J Int AIDS Soc,2014

5. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data;Mollan;Ann Intern Med,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics and adverse effects of anti‐infective drugs in children;Clinical and Experimental Pharmacology and Physiology;2023-10-15

2. Pharmacogenetic effects of single nucleotide polymorphisms commonly associated with antiretroviral therapy metabolism;HIV Infection and Immunosuppressive Disorders;2022-11-10

3. The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes;Medicine;2022-04-29

4. Large variability in plasma efavirenz concentration in Papua New Guinea HIV/AIDS patients associated with high frequency of CYP2B6 516T allele;Clinical and Translational Science;2021-08-20

5. Pharmacogenomics and pharmacokinetics of efavirenz 400 or 600 mg in 184 treatment-naive HIV-infected patients in China;Pharmacogenomics;2020-08